Cite
HARVARD Citation
Gao, B. et al. (2023). A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors. Cancer. 129 (7), pp. 1041-1050. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gao, B. et al. (2023). A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors. Cancer. 129 (7), pp. 1041-1050. [Online].